Pharmaust Ltd
ASX:PAA

Watchlist Manager
Pharmaust Ltd Logo
Pharmaust Ltd
ASX:PAA
Watchlist
Price: 0.165 AUD -8.33%
Market Cap: 81.2m AUD

Intrinsic Value

PAA doesn't have a meaningful market cap.

The intrinsic value of one PAA stock under the Base Case scenario is 0.012 AUD. Compared to the current market price of 0.165 AUD, Pharmaust Ltd is Overvalued by 93%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PAA Intrinsic Value
0.012 AUD
Overvaluation 93%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Pharmaust Ltd

What is Valuation History?
Compare PAA to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PAA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Pharmaust Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pharmaust Ltd

Current Assets 11.1m
Cash & Short-Term Investments 9.7m
Receivables 18.5k
Other Current Assets 1.4m
Efficiency

Free Cash Flow Analysis
Pharmaust Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Pharmaust Ltd

Revenue
866.2k AUD
Operating Expenses
-6.7m AUD
Operating Income
-5.8m AUD
Other Expenses
-1.9m AUD
Net Income
-7.7m AUD
Fundamental Scores

PAA Profitability Score
Profitability Due Diligence

Pharmaust Ltd's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

Strong 3Y Average Gross Margin
Declining Net Margin
Low Gross Margin
Declining Operating Margin
13/100
Profitability
Score

Pharmaust Ltd's profitability score is 13/100. The higher the profitability score, the more profitable the company is.

PAA Solvency Score
Solvency Due Diligence

Pharmaust Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Pharmaust Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PAA Price Targets Summary
Pharmaust Ltd

There are no price targets for PAA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Pharmaust Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for PAA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PAA stock?

The intrinsic value of one PAA stock under the Base Case scenario is 0.012 AUD.

Is PAA stock undervalued or overvalued?

Compared to the current market price of 0.165 AUD, Pharmaust Ltd is Overvalued by 93%.

Back to Top